BMI, spKt/V, and SBP but Not DBP Are Related to LVH in Chinese Maintenance Hemodialysis Patients

REFERENCES

• Cheung AK, Sarnak MJ, Yan G, Cardiac diseases in maintenance hemodialysis patients: Results of the HEMO study. Kidney Int. 2004;65:2380–2389.
   PubMed Web of Science ®Google Scholar
• Lopez-Gomez JM, Verde E, Perez-Garcia R. Blood pressure, left ventricular hypertrophy and long-term prognosis in hemodialysis patients. Kidney Int Suppl. 1998;68:S92–S98.
   Google Scholar
• Parfrey PS, Foley RN, Harnett JD, Kent GM, Murray DC, Barre PE. Outcome and risk factors for left ventricular disorders in chronic uraemia. Nephrol Dial Transplant. 1996;11:1277–1285.
   PubMed Web of Science ®Google Scholar
• Foley RN, Parfrey PS, Harnett JD, Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int. 1995;47:186–192.
   PubMed Web of Science ®Google Scholar
• Levin A, Singer J, Thompson CR, Ross H, Lewis M. Prevalent left ventricular hypertrophy in the predialysis population: Identifying opportunities for intervention. Am J Kidney Dis. 1996;27:347–354.
   PubMed Web of Science ®Google Scholar
• Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation. 1977;55:613–618.
   PubMed Web of Science ®Google Scholar
• de Simone G, Daniels SR, Devereux RB, Left ventricular mass and body size in normotensive children and adults: Assessment of allometric relations and impact of overweight. J Am Coll Cardiol. 1992;20:1251–1260.
   PubMed Web of Science ®Google Scholar
• Visscher TL, Seidell JC, Menotti A, Underweight and overweight in relation to mortality among men aged 40–59 and 50–69 years: The Seven Countries Study. Am J Epidemiol. 2000;151:660–666.
   PubMed Web of Science ®Google Scholar
• Adams KF, Schatzkin A, Harris TB, Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med. 2006;355:763–778.
   PubMed Web of Science ®Google Scholar
• Kalantar-Zadeh K, Abbott KC, Salahudeen AK, Kilpatric RD, Horwich TB. Survival advantages of obesity in dialysis patients. Am J Clin Nutr. 2005;81:543–554.
   PubMed Web of Science ®Google Scholar
• Madero M, Sarnak MJ, Wang X, Body mass index and mortality in CKD. Am J Kidney Dis. 2007;50:404–411.
   Google Scholar
• Stabouli S, Kotsis V, Rizos Z, Left ventricular mass in normotensive, prehypertensive and hypertensive children and adolescents. Pediatr Nephrol. 2009;24:1545–1551.
   PubMed Web of Science ®Google Scholar
• Toprak A, Reddy J, Chen W, Srinivasan S, Berenson G. Relation of pulse pressure and arterial stiffness to concentric left ventricular hypertrophy in young men (from the Bogalusa Heart Study). Am J Cardiol. 2009;103:978–984.
   Web of Science ®Google Scholar
• Vlahakos DV, Hahalis G, Vassilakos P, Marathias KP, Geroulanos S. Relationship between left ventricular hypertrophy and plasma renin activity in chronic hemodialysis patients. J Am Soc Nephrol. 1997;8:1764–1770.
   PubMed Web of Science ®Google Scholar
• Ventura JE, Tavella N, Romero C, Petraglia A, Baez A, Munoz L. Aortic valve calcification is an independent factor of left ventricular hypertrophy in patients on maintenance hemodialysis. Nephrol Dial Transplant. 2002;17:1795–1801.
   PubMed Web of Science ®Google Scholar
• Stevens J, Cai J, Pamuk ER, Williamson DF, Thun MJ, Wood JL. The effect of age on the association between body-mass index and mortality. N Engl J Med. 1998;338:1–7.
   PubMed Web of Science ®Google Scholar
• Leavey SF, McCullough K, Hecking E, Goodkin D, Port FK, Young EW. Body mass index and mortality in ‘healthier’ as compared with ‘sicker’ hemodialysis patients: Results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant. 2001;16:2386–2394.
   PubMed Web of Science ®Google Scholar
• Held PJ, Port FK, Wolfe RA, The dose of hemodialysis and patients mortality. Kidney Int. 1996;50:550–556.
   PubMed Web of Science ®Google Scholar
• Eknoyan G, Beck GJ, Cheung AK, Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med. 2002;347:2010–2019.
   PubMed Web of Science ®Google Scholar
• Hsu HJ, Wu MS. Fibroblast growth factor 23: A possible cause of left ventricular hypertrophy in hemodialysis patients. Am J Med Sci. 2009;337:116–122.
   PubMed Web of Science ®Google Scholar
• Maduell F, Navarro V, Torregrosa E, Change from three times a week on-line hemodiafiltration to short daily on-line hemodiafiltration. Kidney Int. 2003;64:305–313.
   Google Scholar
• Ishimitsu T, Nakano N, Sudo Y, Predictive significance of blood pressure values for the incidence of cardiovascular events in chronic hemodialysis patients. Hypertens Res. 2008;31:1703–1709.
   Google Scholar
• Foley RN, Curtis BM, Randell EW, Parfrey PS. Left ventricular hypertrophy in new hemodialysis patients without symptomatic cardiac disease. Clin J Am Soc Nephrol. 2010;5:805–813.
   PubMed Web of Science ®Google Scholar
• Kutlay S, Dincer I, Sengul S, Nergizoglu G, Duman N, Erturk S. The long-term behavior and predictors of left ventricular hypertrophy in hemodialysis patients. Am J Kidney Dis. 2006;47:485–492.
   PubMed Web of Science ®Google Scholar
• Matsumoto N, Ishimitsu T, Okamura A, Seta H, Takahashi M, Matsuoka H. Effects of imidapril on left ventricular mass in chronic hemodialysis patients. Hypertens Res. 2006;29:253–260.
   PubMed Web of Science ®Google Scholar